HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D NIH Conference Experts Support Raising Upper Limit

This article was originally published in The Tan Sheet

Executive Summary

Supplement trade groups support NIH conference experts' recommendations to increase vitamin D research for identifying an increased Tolerable Upper Intake Level and urge the scientific community not to delay in taking active steps to increase the UL

You may also be interested in...



“All-Time High” Vitamin D Awareness May Make New DRI Less Relevant – CRN

Consumer enthusiasm for vitamin D is outpacing the research community and may make upping the dietary reference intake level less relevant to the supplement industry

ODS Recognizes Vitamin D Studies Among Supplement Research In 2006

Five studies on the health benefits and disease prevention properties of vitamin D are among the 25 advances in dietary supplement research for 2006 recognized by the National Institutes of Health's Office of Dietary Supplements

Report Links Vitamin D3 To Cancer Prevention, Calls For Replacing D2

A report linking vitamin D3 with decreased cancer risk calls for the supplement and nutrition industries to use vitamin D3 rather than vitamin D2 in their products, which could create challenges for manufacturers, industry sources observe

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel